Leanne Amitzi, MSc

PROLOR BIOTECH
Clinical
Papers:
PRE-CLINICAL CHARACTERIZATION OF MOD-4023, A LONG ACTING GROWTH HORMONE
Development of A Population Pharmacokinetic and Pharmacodynamic Model Following A Phase II, Study of MOD-4023 in Growth Hormone Deficient Adults
Metabolic and Safety Parameters of Once-Weekly, CTP-Modified Human Growth Hormone (MOD-4023): Results of a Phase 2 Dose and Frequency Finding Study